UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 56

Sortiert nach

Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations

Lancet neurology, 2007-12, Vol.6 (12), p.1094-1105

2007

Link zum Volltext

Verfügbarkeit prüfen

Definitions, diagnosis, and decompression in spinal surgery: problems and solution

The spine journal, 2015-03, Vol.15 (3), p.S5-S8

2015

Link zum Volltext

Verfügbarkeit prüfen

MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial

Journal of neurology, neurosurgery and psychiatry, 2012-11, Vol.83 (11), p.1125-1132

2012

Link zum Volltext

Verfügbarkeit prüfen

Patient-orientated longitudinal study of multiple sclerosis in south west England (The South West Impact of Multiple Sclerosis Project, SWIMS) 1: protocol and baseline characteristics of cohort

BMC neurology, 2010-10, Vol.10 (1), p.88-88, Article 88

2010

Link zum Volltext

Verfügbarkeit prüfen

What sample sizes for reliability and validity studies in neurology?

Journal of neurology, 2012-12, Vol.259 (12), p.2681-2694

2012

Link zum Volltext

Verfügbarkeit prüfen

The ADAS-cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts

Journal of neurology, neurosurgery and psychiatry, 2010-12, Vol.81 (12), p.1363-1368

2010

Link zum Volltext

Verfügbarkeit prüfen

A tool to measure the attributes of receiving IV therapy in a home versus hospital setting: the Multiple Sclerosis Relapse Management Scale (MSRMS)

Health and quality of life outcomes, 2011-09, Vol.9 (1), p.80-80, Article 80

2011

Link zum Volltext

Verfügbarkeit prüfen

The problem with health measurement

Patient preference and adherence, 2011-01, Vol.5 (default), p.279-290

2011

Link zum Volltext

Verfügbarkeit prüfen

The cervical dystonia impact profile (CDIP-58): can a Rasch developed patient reported outcome measure satisfy traditional psychometric criteria?

Health and quality of life outcomes, 2008-08, Vol.6 (1), p.58-58, Article 58

2008

Link zum Volltext

Verfügbarkeit prüfen

Patient-based outcomes of cervical dystonia: A review of rating scales

Movement disorders, 2004-09, Vol.19 (9), p.1054-1059

2004

Link zum Volltext

Verfügbarkeit prüfen

Effect sizes can be misleading: is it time to change the way we measure change?

Journal of neurology, neurosurgery and psychiatry, 2010-09, Vol.81 (9), p.1044-1048

2010

Link zum Volltext

Verfügbarkeit prüfen

Quality of life measurement after stroke: Uses and abuses of the SF-36

Stroke (1970), 2002-05, Vol.33 (5), p.1348-1356

2002

Link zum Volltext

Verfügbarkeit prüfen

Watch out, watch out, the FDA are about

Developmental medicine and child neurology, 2008-06, Vol.50 (6), p.408-409

2008

Link zum Volltext

Verfügbarkeit prüfen

Modafinil for multiple sclerosis fatigue: Does it work?

Clinical neurology and neurosurgery, 2010-01, Vol.112 (1), p.29-31

2010

Link zum Volltext

Verfügbarkeit prüfen

The size of the treatment effect: do patients and proxies agree?

BMC neurology, 2009-03, Vol.9 (12), p.12-12, Article 12

2009

Link zum Volltext

Verfügbarkeit prüfen

International cooperative ataxia rating scale (ICARS): Appropriate for studies of Friedreich's ataxia?

Movement disorders, 2005-12, Vol.20 (12), p.1585-1591

2005

Link zum Volltext

Verfügbarkeit prüfen

Friedreich's ataxia impact scale: A new measure striving to provide the flexibility required by today's studies

Movement disorders, 2009-05, Vol.24 (7), p.984-992

2009

Link zum Volltext

Verfügbarkeit prüfen

Evidence-based guidelines for using the Short Form 36 in cervical dystonia

Movement disorders, 2007-01, Vol.22 (1), p.122-127

2007

Link zum Volltext

Verfügbarkeit prüfen

Exploring rating scale responsiveness: does the total score reflect the sum of its parts?

Neurology, 2004-05, Vol.62 (10), p.1842

2004

Link zum Volltext

Verfügbarkeit prüfen

Coordinating outcomes measurement in ataxia research: Do some widely used generic rating scales tick the boxes?

Movement disorders, 2006-09, Vol.21 (9), p.1396-1403

2006

Link zum Volltext

Verfügbarkeit prüfen

Socio-demographic variables are limited predictors of health status in multiple sclerosis

Journal of neurology, 2003-09, Vol.250 (9), p.1088-1093

2003

Link zum Volltext

Verfügbarkeit prüfen

Evidence-based measurement: which disability scale for neurologic rehabilitation?

Neurology, 2001-08, Vol.57 (4), p.639

2001

Link zum Volltext

Verfügbarkeit prüfen

Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples

Journal of neurology, neurosurgery and psychiatry, 2002-12, Vol.73 (6), p.701-704

2002

Link zum Volltext

Verfügbarkeit prüfen

Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson’s disease with normal population health profiles

Journal of neurology, neurosurgery and psychiatry, 2003-06, Vol.74 (6), p.710-714

2003

Link zum Volltext

Verfügbarkeit prüfen

1858/An Empirical Demonstration of the Limitations of Classical Test Theory and the Advantages of New Psychometric Methods

Quality of life research, 2003-11, Vol.12 (7), p.744-744

Jeremy C. Hobart

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(56)

Sprache

Englisch
(56)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations

Definitions, diagnosis, and decompression in spinal surgery: problems and solution

MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial

Patient-orientated longitudinal study of multiple sclerosis in south west England (The South West Impact of Multiple Sclerosis Project, SWIMS) 1: protocol and baseline characteristics of cohort

What sample sizes for reliability and validity studies in neurology?

The ADAS-cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts

A tool to measure the attributes of receiving IV therapy in a home versus hospital setting: the Multiple Sclerosis Relapse Management Scale (MSRMS)

The problem with health measurement

The cervical dystonia impact profile (CDIP-58): can a Rasch developed patient reported outcome measure satisfy traditional psychometric criteria?

Patient-based outcomes of cervical dystonia: A review of rating scales

Effect sizes can be misleading: is it time to change the way we measure change?

Quality of life measurement after stroke: Uses and abuses of the SF-36

Watch out, watch out, the FDA are about

Modafinil for multiple sclerosis fatigue: Does it work?

The size of the treatment effect: do patients and proxies agree?

International cooperative ataxia rating scale (ICARS): Appropriate for studies of Friedreich's ataxia?

Friedreich's ataxia impact scale: A new measure striving to provide the flexibility required by today's studies

Evidence-based guidelines for using the Short Form 36 in cervical dystonia

Exploring rating scale responsiveness: does the total score reflect the sum of its parts?

Coordinating outcomes measurement in ataxia research: Do some widely used generic rating scales tick the boxes?

Socio-demographic variables are limited predictors of health status in multiple sclerosis

Evidence-based measurement: which disability scale for neurologic rehabilitation?

Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples

Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson’s disease with normal population health profiles

1858/An Empirical Demonstration of the Limitations of Classical Test Theory and the Advantages of New Psychometric Methods

Suchergebnisse filtern